Back to top
more

GSK PLC Sponsored ADR (GSK)

(Delayed Data from NYSE)

$40.91 USD

40.91
3,015,243

+0.05 (0.12%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $40.92 +0.01 (0.02%) 4:36 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (69 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for GSK

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for GSK PLC Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 6,608 9,978 6,220 8,374 6,649
Receivables 9,650 9,225 11,477 9,788 9,531
Notes Receivable 0 0 0 0 0
Inventories 6,839 6,365 7,952 7,699 7,594
Other Current Assets 95 121 30 136 1,115
Total Current Assets 23,191 25,689 25,679 25,997 24,888
Net Property & Equipment 11,220 11,049 13,657 13,066 13,213
Investments & Advances 1,483 1,906 3,069 4,403 2,878
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 7,524 6,998 7,175 5,505 5,230
Intangibles 26,842 26,425 55,872 51,901 53,013
Deposits & Other Assets 1,970 1,477 2,305 1,337 1,302
Total Assets 73,396 74,395 108,775 103,273 101,759
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 19,708 20,116 24,139 20,339 19,076
Current Portion Long-Term Debt 3,499 4,888 4,952 4,783 8,834
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 622 583 672 700 803
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 2,377 2,627 2,786 2,617 1,997
Total Current Liabilities 26,206 28,214 32,549 28,438 30,709
Mortgages 0 0 0 0 0
Deferred Taxes/Income 387 357 4,890 4,622 4,865
Convertible Debt 0 0 0 0 0
Long-Term Debt 18,914 21,071 28,289 30,078 30,122
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 11,974 12,265 13,700 13,418 12,622
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 57,481 61,907 79,427 76,556 78,319
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1,677 1,666 1,852 1,728 1,719
Capital Surplus 4,293 4,255 4,539 4,213 4,053
Retained Earnings 9,005 5,397 10,924 8,673 5,784
Other Equity 942 1,170 12,032 12,103 11,884
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 15,916 12,488 29,347 26,717 23,440
Total Liabilities & Shareholder's Equity 73,396 74,395 108,775 103,273 101,759
Total Common Equity 15,916 12,488 29,347 26,717 23,440
Shares Outstanding 2,057.50 2,155.60 2,154.00 2,154.00 1,995.30
Book Value Per Share 7.74 5.79 13.62 12.40 11.75

Fiscal Year End for GSK PLC Sponsored ADR falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 6,608 8,641 8,349 8,625
Receivables NA 9,650 11,234 8,884 8,660
Notes Receivable NA 0 0 0 0
Inventories NA 6,839 6,937 6,902 6,505
Other Current Assets NA 95 76 91 164
Total Current Assets NA 23,191 26,888 24,226 23,955
Net Property & Equipment NA 11,220 11,158 10,844 10,639
Investments & Advances NA 1,483 1,446 1,690 1,628
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 7,524 7,102 7,261 6,815
Intangibles NA 26,842 28,189 27,855 25,531
Deposits & Other Assets NA 1,970 1,453 1,755 1,817
Total Assets NA 73,396 77,045 74,451 71,182
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 19,708 19,725 17,468 17,333
Current Portion Long-Term Debt NA 3,499 6,131 7,414 5,176
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 622 362 681 515
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 2,377 2,125 2,119 2,117
Total Current Liabilities NA 26,206 28,344 27,681 25,142
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 387 509 626 352
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 18,914 20,246 19,474 20,219
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 11,973 11,445 11,728
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 57,481 61,071 59,227 57,441
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1,677 1,706 1,688 1,638
Capital Surplus NA 4,293 4,367 4,320 4,190
Retained Earnings NA 9,005 8,883 8,036 6,870
Other Equity NA 942 1,018 1,181 1,045
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 15,916 15,974 15,224 13,742
Total Liabilities & Shareholder's Equity NA 73,396 77,045 74,451 71,182
Total Common Equity 0 15,916 15,974 15,224 13,742
Shares Outstanding 2,072.40 2,057.50 2,047.50 2,047.50 2,047.40
Book Value Per Share 0.00 7.74 7.80 7.44 6.71